جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

7 مُخرَج نتائج البحث عن «COPD»

مراجعةوصول مفتوح2026

Evaluating the therapeutic benefit of bacterial lysates in chronic obstructive pulmonary disease: a systematic review and meta-analysis

Frontiers in Medicine · مجلد 13

Background Chronic obstructive pulmonary disease (COPD) with exacerbations often triggered by infections. Bacterial lysates have been investigated as interventions to reduce the exacerbations of COPD. Methods We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating bacterial lysates (BLs) in adults with chronic obstructive pulmonary disease (COPD). PubMed, EMBASE, CENTRAL, Web of Science, Google Scholar, ICTRP, and ClinicalTrials.gov were searched. In adults with COPD that compared bacterial lysates with placebo or conventional COPD therapy. Primary outcomes were the effect of BLs on exacerbations and duration. Secondary outcomes were hospitalisation risk, the mean number of exacerbations per participant during trial follow up, symptom scores for dyspnoea, sputum, cough, and adverse events. We used random-effects meta-analysis, assessed risk of bias with Cochrane RoB 2, graded certainty with GRADE. Results Fifteen RCTs were included. The pooled risk ratio (RR) for exacerbation in patients with COPD treated with BLs vs. control was 0.83 (95% CI 0.74–0.93; P = 0.0009). The mean difference (MD) for exacerbation duration showed no statistical significant reduction −9.26 Days (95% CI −19.56 to 1.03; P = 0.08). Mean number of exacerbations (MD) −0.19 (95% CI −0.30 to −0.08; P = 0.0009). Hospitalisation RR was 0.52 (95% CI 0.35–0.78; P = 0.001).Symptom outcomes were dyspnoea standardised mean difference (SMD) −0.42 (95% CI −0.75 to −0.10; P = 0.01), cough (SMD) −0.37 (95% CI −0.63 to −0.11; P = 0.006), while sputum production showed no significant change (SMD) −0.20 (95% CI −0.65 to 0.25; P = 0.39), The RR for adverse events was 0.95 (95% CI 0.86–1.04; P = 0.27). Conclusion Bacterial lysates may be associated with lower COPD exacerbation and hospitalisation risk, with small numerical improvements in dyspnoea, cough, sputum production showed no significant improvement; effects varied by formulation, these findings require confirmation in formulation specific trials. Systematic Review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD42024570783 , PROSPERO CRD42024570783.

chronic obstructive pulmonary diseasebacterial extractsCOPD exacerbationshospitalization
مقالوصول مفتوح2026

Barriers Facing the Hospitals from Establishing Pulmonary Rehabilitation Programs in the Usual Care of COPD and Respiratory Patients in Saudi Arabia

Journal of Multidisciplinary Healthcare · مجلد Volume 19 · 1-11

Background: The prevalence of pulmonary diseases, including chronic obstructive pulmonary diseases, in Saudi Arabia is high, and pulmonary rehabilitation is not available in most Saudi hospitals. The causes that prevent hospitals in Saudi Arabia are still unclear and need more investigation. Thus, the aim of this study is to determine why pulmonary rehabilitation is not part of the usual COPD and respiratory disease management in Saudi Arabia. Methods: A cross-sectional study was conducted in Saudi Arabia with two questionnaires: the first for the healthcare providers and the second for pulmonary patients. Results: About 349 healthcare providers completed the first questionnaire. The three highest barriers for establishing pulmonary rehabilitation in Saudi Arabia were shortage of healthcare providers (n = 183), followed by reduction of funds (n = 146) and lack of hospital room and capacity, respectively (n = 101 and n = 78). From the healthcare provider's point of view, the two highest barriers to preventing patients from attending pulmonary rehabilitation were transportation (n = 151), followed by lack of perceived benefits (n = 142). Almost half of healthcare providers (44%) intended to implement percentage a pulmonary rehabilitation program in Saudi Arabia. About 269 pulmonary patients filled out the second questionnaire. The three highest barriers from the patients' point of view to attend the pulmonary rehabilitation were being consistent with the program, lack of transportation, and wasting time in the program. Conclusion: The main barriers that prevent the implementation of a pulmonary rehabilitation program were lack of healthcare professionals and funds and low hospital capacity. The most barriers that prevent pulmonary patients from attending pulmonary rehabilitation programs were transportation challenges and lack of perceived benefits. About half of the healthcare providers intended to implement a pulmonary rehabilitation program in Saudi Arabia.

pulmonary rehabilitationchronic obstructive pulmonary diseaseimplementation barriershealthcare provider shortage
مراجعةوصول مفتوح202510استشهاد· Semantic Scholar

Artificial Intelligence-Powered Chronic Obstructive Pulmonary Disease Detection Techniques—A Review

Diagnostics · مجلد 15 (20) · 2562-2562

Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition, contributing significantly to global morbidity and mortality. Traditional diagnostic tools are effective in diagnosing COPD. However, these tools demand specialized equipment and expertise. Advances in artificial intelligence (AI) provide a platform for enhancing COPD diagnosis by leveraging diverse data modalities. The existing reviews primarily focus on single modalities and lack information on interpretability and explainability. Thus, this review intends to synthesize the AI-powered frameworks for COPD identification, focusing on data modalities, methodological innovation, evaluation strategies, and reporting limitations and potential biases. By adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic search was conducted across multiple repositories. From an initial pool of 1978 records, 22 studies were included in this review. The included studies demonstrated exceptional performance in specific settings. Most studies were retrospective and limited in diversity, lacking generalizability and external or prospective validation. This review presents a roadmap for advancing AI-assisted COPD detection. By highlighting the strengths and limitations of existing studies, it supports the development of future research. Future studies can utilize the findings to build models using prospective, multicenter, and multi-ethnic validations, ensuring generalizability and fairness.

chronic obstructive pulmonary diseaseCOPD detectionartificial intelligencemachine learning
مقالوصول مفتوح20251استشهاد· Semantic Scholar

Optimized Kolmogorov–Arnold Networks-Driven Chronic Obstructive Pulmonary Disease Detection Model

IEEE Access · مجلد 13 · 162947-162960

Across the globe, chronic obstructive pulmonary disease (COPD) continues to be a critical healthcare burden due to its progressive and undetected decline in pulmonary function. In recent times, convolutional neural networks (CNNs) and vision transformers (ViTs) have been widely applied to lung sounds (LS) analysis, leading to the development of improved non-invasive, accessible, and scalable COPD screening methods. However, the shortcomings of CNNs and ViTs architectures restrict the COPD classifier’s discriminative power in distinguishing normal and COPD samples. In this study, a unique and interpretable COPD classification is proposed. This study introduces a hybrid feature extraction strategy integrating CNNs and ViTs architecture to capture the crucial COPD patterns from the LS’s Mel-spectrogram representation. The proposed CNNs-ViTs architecture addresses the limitations of standalone CNNs or ViTs architectures by capturing fine-grained acoustic features and long-range temporal dependencies while efficiently modeling non-linear relationships. A novel feature fusion is used to combine the heterogeneous features into a unified and highly discriminative feature representation space. A tailored hyperparameter optimization strategy is developed to fine-tune the Kolmogorov-Arnold Networks (KANs) for classifying the features into normal and COPD classes. By incorporating internal (552 Healthy and 1324 COPD LS recordings) and external (35 Healthy and 77 COPD LS recordings) datasets, the authors evaluate the model’s performance. The model achieves a generalization accuracy of 97.62% and specificity of 96.51% on the external dataset. Through Shapley Additive Explanations (SHAP) overlays, the model’s interpretability is enhanced. The experimental findings highlight the effectiveness of the proposed COPD classification architecture in the domain of biomedical acoustic signal processing. Operating with minimal reliance on specialized diagnostic infrastructure renders the proposed model ideal for primary care and resource-limited environments.

chronic obstructive pulmonary diseaseCOPD detectionlung sound analysisKolmogorov-Arnold networks
مقالمفتوح (مستودع)2024

Effectiveness of TheraPEP Versus Conventional Breathing Techniques in Managing Acute COPD Exacerbations

International Journal of Physical Therapy Research & Practice · مجلد 3 (8) · 333-339

Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide, often complicated by acute exacerbations that impair lung function and quality of life. Effective airway clearance techniques are essential in managing exacerbations, but the comparative effectiveness of different methods remains unclear. This study aimed to evaluate the short-term effectiveness of TheraPEP, a positive expiratory pressure (PEP) device, versus the Active Cycle of Breathing Technique (ACBT) in managing acute COPD exacerbations. Methods: A randomized controlled trial (RCT) was conducted with 60 patients (≥40 years) admitted with acute exacerbations of COPD. Participants were randomly assigned to either the TheraPEP group (n=30) or the ACBT group (n=30). Each group received three daily sessions of their assigned therapy throughout their hospital stay. Primary outcomes included dyspnea, measured by the modified Borg Dyspnea Scale, and secondary outcomes included sputum clearance, lung function (FEV1, FVC, and FEV1/FVC ratio), oxygen saturation (SpO₂), and quality of life, measured by the Breathlessness, Cough, and Sputum Scale (BCSS). Data were collected at baseline, discharge, and 14-day follow-up. A two-way repeated-measures ANOVA was used to examine changes in dyspnea, lung function, sputum clearance, SpO₂, and BCSS scores over time (baseline, discharge, and 14-day follow-up) within and between groups. The main effects of time (within-subject factor) and group (between-subject factor) were assessed, along with the interaction effects (time × group). Results: Both groups demonstrated significant improvements in dyspnea, lung function, and quality of life from baseline to discharge and follow-up. However, the TheraPEP group showed significantly greater improvements in sputum clearance (p=0.01), oxygen saturation (p=0.03), and BCSS scores (p=0.03) compared to the ACBT group. No significant between-group differences were found for FEV1, FVC, or FEV1/FVC ratio (p > 0.05). Conclusions: Both TheraPEP and ACBT are effective in managing acute COPD exacerbations, but TheraPEP offers additional benefits in terms of sputum clearance and oxygenation. These findings suggest that TheraPEP may be more suitable for patients with severe mucus hypersecretion. Further research is warranted to assess the long-term effects of these therapies on COPD progression and patient outcomes.

positive expiratory pressureacute COPD exacerbationairway clearance techniquesactive cycle of breathing technique
مقالمفتوح (مستودع)2022

Effect of Primary Care on Reducing Rates of Hospitalization Among Chronic Obstructive Pulmonary Disease Patients

Journal of Healthcare Sciences · مجلد 02 (11) · 478-483

The normal course of Chronic obstructive pulmonary disease (COPD) includes a progressive reduction in lung function, exacerbations that necessitate primary care intervention or hospital admission, a steady decline in quality of life, and a shorter life expectancy. COPD is one of the ambulatory or primary care-sensitive illnesses for which it is hypothesized that efficient primary care management will lower the probability of hospital admission. Long-acting beta-agonist and inhaler steroid combination therapy improves spirometric results and overall health while lowering the annual risk of COPD exacerbations. Use of two or more treatment modules based on models designed specifically for chronic care delivery in developed countries have proven successful in lowering hospitalizations as well. Access to other therapies, such as pulmonary rehabilitation, acute exacerbation evaluation programs, and community or hospital-based respiratory specialists, may also be important. The goal of interventions to lessen the prevalence of COPD in underserved areas has to focus on locally driven integrated solutions, such as media campaigns to raise awareness and persuade at-risk individuals to get tested, as well as training for primary care workers on the significance and advantages of earlier detection and effective operation of chronic obstructive pulmonary disease. Importantly, uptake of influenza vaccination has demonstrated a link with hospital admission rates at the practice level. Proposed solutions for lowering hospitalization and reducing exacerbations among patients with COPD include greater access to pulmonary rehabilitative care, more rigorous implementation of smoking cessation programs and availability of modern long-acting medications.

chronic obstructive pulmonary diseasehospitalization ratesprimary careCOPD exacerbations
مراجعةوصول مفتوح202113استشهاد· Semantic Scholar

Current Overview on Therapeutic Potential of Vitamin D in Inflammatory Lung Diseases

Biomedicines · مجلد 9 (12) · 1843-1843

Inflammatory lung disorders (ILDs) are one of the world's major reasons for fatalities and sickness, impacting millions of individuals of all ages and constituting a severe and pervasive health hazard. Asthma, lung cancer, bronchiectasis, pulmonary fibrosis acute respiratory distress syndrome, and COPD all include inflammation as a significant component. Microbe invasions, as well as the damage and even death of host cells, can cause and sustain inflammation. To counteract the negative consequences of irritants, the airways are equipped with cellular and host defense immunological systems that block the cellular entrance of these irritants or eliminate them from airway regions by triggering the immune system. Failure to activate the host defense system will trigger chronic inflammatory cataracts, leading to permanent lung damage. This damage makes the lungs more susceptible to various respiratory diseases. There are certain restrictions of the available therapy for lung illnesses. Vitamins are nutritional molecules that are required for optimal health but are not produced by the human body. Cholecalciferol (Vitamin D) is classified as a vitamin, although it is a hormone. Vitamin D is thought to perform a function in bone and calcium homeostasis. Recent research has found that vitamin D can perform a variety of cellular processes, including cellular proliferation; differentiation; wound repair; healing; and regulatory systems, such as the immune response, immunological, and inflammation. The actions of vitamin D on inflammatory cells are dissected in this review, as well as their clinical significance in respiratory illnesses.

vitamin Dvitamin D3inflammatory lung diseaseairway inflammation